Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

First-in-human study of Opal-HIV-Gag(c) terminated

Sep. 25, 2012

Itraconazole shows promise as an antiangiogenic and antitumor agent

Sep. 25, 2012

Bayer College of Medicine presents novel Ndufs4-mutant mouse model

Sep. 21, 2012

Plasma serotonin as indicator of stable heart disease outcomes

Sep. 21, 2012

Identification of a new series of potent and selective NS5B inhibitors

Sep. 21, 2012

Theravance presents new dual MABA bronchodilators for COPD

Sep. 21, 2012

Afatinib demonstrates significant improvements in PFS in the LUX-lung 3 phase III trial

Sep. 21, 2012

Bionor Pharma presents phase II results for HIV vaccine

Sep. 20, 2012

Urinary CCL18 assessed as a biomarker for Gaucher's disease

Sep. 20, 2012

Dompe presents new TRPM8 antagonists with potent activity in neuropathic pain models

Sep. 20, 2012

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026